Guobang Pharma Ltd. Class ASSE: 605507

Announcement on the Passing of U.S. FDA On-site Inspection of Florfenicol, a Wholly-owned Subsidiary's Product

· Issued by Guobang Pharma Ltd. Class A via Shanghai Stock Exchange
Announcement on the Passing of U.S. FDA On-site Inspection of Florfenicol, a Wholly-owned Subsidiary's Product

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis